Comparing U.S. Physical medication (NYSE |USPH) & Its Rivals

Physical medication to similar businesses based on the power of its dividends, profitability, earnings, institutional ownership, danger, valuation & analyst recommendations. Physical medication. Physical medication has a beta of one.08, suggesting which its share value is eight% further volatile than the S&P 500. Physical medication rivals win U.S. Physical medication, Inc., out of its subsidiaries, operates outpatient physical medication dispensaries which provide pre-& post-operative care, & curing for orthopedic-linked Complications, sports-linked hurts , preventative care, rehabilitation of infective workers & neurological-linked hurts .

Head to Head Survey: U.S. Physical medication (NYSE |USPH) versus. Its Competitors

Physical medication has a beta of one.08, suggesting which its stock value is eight% further volatile than the S&P 500. Physical medication. Physical medication rivals win U.S. Physical medication, Inc., out of its subsidiaries, operates outpatient physical medication dispensaries which provide pre-& post-operative care, & curing for orthopedic-linked Complications, sports-linked hurts , preventative care, rehabilitation of infective workers & neurological-linked hurts . The Inc. operates 562 physical medication dispensaries in 42 states.

U.S. Physical medication (NYSE |USPH) versus. Its Competitors Head-To-Head test

as informed in Physical medication Competitors 59 331 513 nine two.52U.S. Physical medication Competitors $one.06 bn -$22.56 mn 900.65U.S. Physical medication. Physical medication competitors win U.S. Physical medication, Inc., out of its subsidiaries, operates outpatient physical medication dispensaries which provide pre-& post-operative care, & curing for orthopedic-linked Complications, sports-linked hurts , preventative care, rehabilitation of infective workers & neurological-linked hurts .

collected by :Lucy William